Clinical Experience with Tigecycline in the Treatment of Prosthetic Joint Infections.

The purpose of this study was to examine the use of tigecycline in the treatment of prosthetic joint infection (PJI). : This is a retrospective review performed from 2008 to 2017, examining adult patients with PJI at a tertiary medical referral center who received tigecycline for 75% or greater of the treatment course. Failure was defined as need to return to the operating room for an infectious complication or persistent drainage from the joint.

Candida meningitis in an immunocompetent patient detected through (1→3)-beta-d-glucan.

A 44-year-old female presented with a 3-month history of headache, dizziness, nausea, and vomiting. Her past medical history was significant for long-standing intravenous drug abuse. Shortly after admission, the patient became hypertensive and febrile, with fever as high as 38.